{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:52:33Z","timestamp":1773924753213,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-026-01120-1","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:50:55Z","timestamp":1770670255000},"page":"147-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of pharmacological agents for management of post-partum hypertension: A systematic review and network meta-analysis"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-2756","authenticated-orcid":false,"given":"Alok","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhusudan Prasad","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pushpawati","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer Uttamrao","family":"Khasbage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riya","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"1120_CR1","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","volume":"79","author":"VD Garovic","year":"2022","unstructured":"Garovic VD, Dechend R, Easterling T, Karumanch SA, McMurtry Baird S, Magee LA, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022;79:e21\u201341.","journal-title":"Hypertension"},{"key":"1120_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/1471-0528.16545","volume":"128","author":"V Giorgione","year":"2021","unstructured":"Giorgione V, Ridder A, Kalafat E, Khalil A, Thilaganathan B. Incidence of postpartum hypertension within 2 years of a pregnancy complicated by pre\u2010eclampsia: a systematic review and meta\u2010analysis. BJOG. 2021;128:495\u2013503.","journal-title":"BJOG"},{"key":"1120_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","volume":"71","author":"ND Ford","year":"2022","unstructured":"Ford ND, Cox S, Ko JY, Ouyang L, Romero L, Colarusso T, et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization \u2014 United States, 2017\u20132019. MMWR Morb Mortal Wkly Rep. 2022;71:585\u201391.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1120_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/HYPERTENSIONAHA.122.19275","volume":"80","author":"SE Parker","year":"2023","unstructured":"Parker SE, Ajayi A, Yarrington CD. De novo postpartum hypertension: incidence and risk factors at a safety-net hospital. Hypertension. 2023;80:279\u201387.","journal-title":"Hypertension"},{"key":"1120_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/CIRCULATIONAHA.124.073302","volume":"151","author":"M Countouris","year":"2025","unstructured":"Countouris M, Mahmoud Z, Cohen JB, Crousillat D, Hameed AB, Harrington CM, et al. Hypertension in pregnancy and postpartum: Current standards and opportunities to improve care. Circulation. 2025;151:490\u2013507.","journal-title":"Circulation"},{"key":"1120_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/OGX.0000000000000424","volume":"72","author":"KJ Sharma","year":"2017","unstructured":"Sharma KJ, Kilpatrick SJ. Postpartum hypertension: Etiology, diagnosis, and management. Obstet Gynecol Surv. 2017;72:248\u201352.","journal-title":"Obstet Gynecol Surv"},{"key":"1120_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.12688\/f1000research.12249.1","volume":"7","author":"K Duhig","year":"2018","unstructured":"Duhig K, Vandermolen B, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Res. 2018;7:242.","journal-title":"F1000Res"},{"key":"1120_CR8","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:e1-e25.","DOI":"10.1097\/AOG.0000000000003020"},{"key":"1120_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3109\/10641950902777747","volume":"29","author":"T Podymow","year":"2010","unstructured":"Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy. 2010;29:294\u2013300.","journal-title":"Hypertens Pregnancy"},{"key":"1120_CR10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","volume":"394","author":"T Easterling","year":"2019","unstructured":"Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019;394:1011\u201321.","journal-title":"Lancet"},{"key":"1120_CR11","first-page":"CD001449","volume":"2013","author":"L Duley","year":"2013","unstructured":"Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;2013:CD001449.","journal-title":"Cochrane Database Syst Rev"},{"key":"1120_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11906-020-01058-w","volume":"22","author":"V Katsi","year":"2020","unstructured":"Katsi V, Skalis G, Vamvakou G, Tousoulis D, Makris T. Postpartum hypertension. Curr Hypertens Rep. 2020;22:58.","journal-title":"Curr Hypertens Rep"},{"key":"1120_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/10641955.2022.2056196","volume":"41","author":"HZ Wu","year":"2022","unstructured":"Wu HZ, Cheng Y, Yu D, Li JB, Jiang YF, Zhu ZN. Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials. Hypertens Pregnancy. 2022;41:126\u201338.","journal-title":"Hypertens Pregnancy"},{"key":"1120_CR14","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/bcp.13649","volume":"84","author":"K Sridharan","year":"2018","unstructured":"Sridharan K, Sequeira RP. Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials. Br J Clin Pharmacol. 2018;84:1906\u201316.","journal-title":"Br J Clin Pharmacol"},{"key":"1120_CR15","doi-asserted-by":"publisher","first-page":"e70005","DOI":"10.1002\/pmf2.70005","volume":"1","author":"T Lovgren","year":"2025","unstructured":"Lovgren T, Yao R, Connealy B, Bonebrake R, Satpathy H, Patel E, et al. Impact of labetalol versus nifedipine treatment on readmission risk in postpartum hypertension: A randomized controlled trial. Pregnancy. 2025;1:e70005.","journal-title":"Pregnancy"},{"key":"1120_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777\u201384.","journal-title":"Ann Intern Med"},{"key":"1120_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"J Higgins","year":"2019","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Newark: John Wiley & Sons, Incorporated; 2019. p. 1. (Wiley Cochrane)","edition":"2nd ed."},{"key":"1120_CR18","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"1120_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s42399-025-02000-4","volume":"7","author":"MP Singh","year":"2025","unstructured":"Singh MP, Yadav R, Singh A. Efficacy and Safety of GLP-1 receptor agonists for the management of Knee Osteoarthritis: A systematic review and meta-analysis. SN Compr. Clin. Med. 2025;7:231.","journal-title":"SN Compr. Clin. Med."},{"key":"1120_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/jrsm.1373","volume":"10","author":"RK Owen","year":"2019","unstructured":"Owen RK, Bradbury N, Xin Y, Cooper N, Sutton A. MetaInsight: An interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta. Res Syn Meth. 2019;10:569\u201381.","journal-title":"Res Syn Meth"},{"key":"1120_CR21","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932\u201344.","journal-title":"Stat Med"},{"key":"1120_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2023.02.016","volume":"157","author":"CR Nevill","year":"2023","unstructured":"Nevill CR, Cooper NJ, Sutton AJ. A multifaceted graphical display, including treatment ranking, was developed to aid interpretation of network meta-analysis. J Clin Epidemiol. 2023 May;157:83\u201391.","journal-title":"J Clin Epidemiol"},{"key":"1120_CR23","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"A Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One. 2013;8:e76654.","journal-title":"PLoS One"},{"key":"1120_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2025.101195","volume":"39","author":"RMCP Marques","year":"2025","unstructured":"Marques RMCP, Maia SB, Ara\u00fajo ATV, Ara\u00fajo LMC, Dias TVQ, Nogueira GTBR, et al. Management of hypertension in the early postpartum: A randomized controlled trial. Pregnancy Hypertens. 2025;39:101195.","journal-title":"Pregnancy Hypertens"},{"key":"1120_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2025.101614","volume":"7","author":"T Cursino","year":"2025","unstructured":"Cursino T, Katz L, Coutinho I, de Souza ASR, Silva TV, Cunha ACCda, et al. Postpartum furosemide for accelerating recovery in patients with preeclampsia: a randomized placebo-controlled trial. Am J Obstet Gynecol MFM. 2025;7:101614.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"1120_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2024.101575","volume":"7","author":"K Pratt","year":"2025","unstructured":"Pratt K, Lordo R, Self S, Carlson L. Amlodipine versus nifedipine ER for the management of postpartum hypertension: a noninferiority randomized controlled trial. Am J Obstet Gynecol MFM. 2025;7:101575.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"1120_CR27","doi-asserted-by":"publisher","first-page":"125.e1","DOI":"10.1016\/j.ajog.2024.04.016","volume":"232","author":"UN Emeruwa","year":"2025","unstructured":"Emeruwa UN, Azad H, Ona S, Bejerano S, Alnafisee S, Emont J, et al. Lasix for the prevention of de novo postpartum hypertension: a randomized placebo-controlled trial (LAPP Trial). Am J Obstet Gynecol. 2025;232:125.e1\u2013125.e21.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.101178","volume":"5","author":"EM Yoselevsky","year":"2023","unstructured":"Yoselevsky EM, Seely EW, Celi AC, Robinson JN, McElrath TF. A randomized controlled trial comparing the efficacy of nifedipine and enalapril in the postpartum period. Am J Obstet Gynecol MFM. 2023;5:101178.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"1120_CR29","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41371-023-00841-x","volume":"37","author":"A Gupta","year":"2023","unstructured":"Gupta A, Nayak D, Sharma J, Keepanasseril A. Comparing the efficacy of oral labetalol with oral amlodipine in achieving blood pressure control in women with postpartum hypertension: randomized controlled trial (HIPPO study-Hypertension In Pregnancy & Postpartum Oral-antihypertensive therapy). J Hum Hypertens. 2023;37:1056\u201362.","journal-title":"J Hum Hypertens"},{"key":"1120_CR30","doi-asserted-by":"publisher","first-page":"571.e1","DOI":"10.1016\/j.ajog.2023.01.015","volume":"228","author":"M Fishel Bartal","year":"2023","unstructured":"Fishel Bartal M, Blackwell SC, Pedroza C, Lawal D, Amro F, Samuel J, et al. Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial. Am J Obstet Gynecol. 2023;228:571.e1\u2013571.e10.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR31","first-page":"119","volume":"16","author":"T Suganya","year":"2024","unstructured":"Suganya T, Vijayalakshmi A, Saravanan S, Aarthikarasi R. Comparative study between oral labetalol vs oral labetalol with oral frusemide in control of blood pressure among postpartum mothers with severe pre-eclampsia. Int J Pharm Clin Res. 2024;16:119\u201328.","journal-title":"Int J Pharm Clin Res"},{"key":"1120_CR32","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1161\/HYPERTENSIONAHA.120.16133","volume":"77","author":"J Lopes Perdigao","year":"2021","unstructured":"Lopes Perdigao J, Lewey J, Hirshberg A, Kolper N, Srinivas SK, Elovitz MA, et al. Furosemide for Accelerated Recovery of Blood Pressure Postpartum in women with a hypertensive disorder of pregnancy: A Randomized Controlled Trial. Hypertension. 2021;77:1517\u201324.","journal-title":"Hypertension"},{"key":"1120_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5347918","volume":"2020","author":"G Arias-Hern\u00e1ndez","year":"2020","unstructured":"Arias-Hern\u00e1ndez G, Vargas-De-Le\u00f3n C, Calzada-Mendoza CC, Ocharan-Hern\u00e1ndez ME. Efficacy of diltiazem for the control of blood pressure in puerperal patients with severe preeclampsia: A randomized, single-blind, controlled trial. Int J Hypertens. 2020;2020:5347918.","journal-title":"Int J Hypertens"},{"key":"1120_CR34","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.12669\/pjms.35.5.812","volume":"35","author":"J Ainuddin","year":"2019","unstructured":"Ainuddin J, Javed F, Kazi S. Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial. Pak J Med Sci. 2019;35:1428\u201333.","journal-title":"Pak J Med Sci"},{"key":"1120_CR35","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/10641955.2016.1239735","volume":"36","author":"P Veena","year":"2017","unstructured":"Veena P, Perivela L, Raghavan SS. Furosemide in postpartum management of severe preeclampsia: A randomized controlled trial. Hypertens Pregnancy. 2017;36:84\u201389.","journal-title":"Hypertens Pregnancy"},{"key":"1120_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1080\/10641955.2016.1231317","volume":"36","author":"KJ Sharma","year":"2017","unstructured":"Sharma KJ, Greene N, Kilpatrick SJ. Oral labetalol compared to oral nifedipine for postpartum hypertension: A randomized controlled trial. Hypertens Pregnancy. 2017;36:44\u201347.","journal-title":"Hypertens Pregnancy"},{"key":"1120_CR37","doi-asserted-by":"publisher","first-page":"e0168124","DOI":"10.1371\/journal.pone.0168124","volume":"12","author":"CC Noronha Neto","year":"2017","unstructured":"Noronha Neto CC, Maia SSB, Katz L, Coutinho IC, Souza AR, Amorim MM. Clonidine versus captopril for severe postpartum hypertension: A randomized controlled Trial. PLoS ONE. 2017;12:e0168124.","journal-title":"PLoS ONE"},{"key":"1120_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/10641950701204430","volume":"26","author":"P Vigil-De Gracia","year":"2007","unstructured":"Vigil-De Gracia P, Ruiz E, L\u00f3pez JC, de Jaramillo IA, Vega-Maleck JC, Pinz\u00f3n J. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertens Pregnancy. 2007;26:163\u201371.","journal-title":"Hypertens Pregnancy"},{"key":"1120_CR39","first-page":"118","volume":"6","author":"NC Sayin","year":"2005","unstructured":"Sayin NC, Altundag G, Varol FG. Efficacy of alpha-methyldopa and nifedipine in the treatment of postpartum hypertension. J Turk Ger Gynecol Assoc. 2005;6:118\u201322.","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"1120_CR40","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1161\/HYPERTENSIONAHA.120.15875","volume":"76","author":"L Ormesher","year":"2020","unstructured":"Ormesher L, Higson S, Luckie M, Roberts SA, Glossop H, Trafford A, et al. Postnatal enalapril to improve cardiovascular function following preterm preeclampsia (PICk-UP):: A randomized double-blind placebo-controlled feasibility trial. Hypertension. 2020;76:1828\u201337.","journal-title":"Hypertension"},{"key":"1120_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee LA, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy KE, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407\u201317.","journal-title":"N Engl J Med"},{"key":"1120_CR42","doi-asserted-by":"publisher","first-page":"100517","DOI":"10.1016\/j.ajogmf.2021.100517","volume":"4","author":"T Lovgren","year":"2022","unstructured":"Lovgren T, Connealy B, Yao R, Dahlke JD. Postpartum management of hypertension and effect on readmission rates. Am J Obstet Gynecol MFM. 2022;4:100517.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"1120_CR43","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/AOG.0000000000004918","volume":"140","author":"SC Do","year":"2022","unstructured":"Do SC, Leonard SA, Kan P, Panelli DM, Girsen AI, Lyell DJ, El-Sayed YY, et al. Postpartum readmission for hypertension after discharge on labetalol or nifedipine. Obstet Gynecol. 2022;140:591\u20138.","journal-title":"Obstet Gynecol"},{"key":"1120_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/HJH.0000000000003340","volume":"41","author":"T Lovgren","year":"2023","unstructured":"Lovgren T, Connealy B, Yao R, Dahlke JD. Postpartum medical management of hypertension and risk of readmission for hypertensive complications. J Hypertens. 2023;41:351\u20135.","journal-title":"J Hypertens"},{"key":"1120_CR45","doi-asserted-by":"crossref","unstructured":"Mitro SD, Hedderson M, Xu F, Forquer H, Baker JM, Kuzniewicz MW, Greenberg M. Risk of postpartum readmission after hypertensive disorder of pregnancy and variation by discharge antihypertensive medication prescription. Am J Obstet Gynecol. 2024;231:456.13.","DOI":"10.1016\/j.ajog.2024.01.015"},{"key":"1120_CR46","doi-asserted-by":"publisher","first-page":"e018696","DOI":"10.1136\/bmjopen-2017-018696","volume":"7","author":"AE Cairns","year":"2017","unstructured":"Cairns AE, Pealing L, Duffy JMN, Roberts N, Tuck KL, Leeson P, et al. Postpartum management of hypertensive disorders of pregnancy: A systematic review. BMJ Open. 2017;7:e018696.","journal-title":"BMJ Open"},{"key":"1120_CR47","doi-asserted-by":"publisher","first-page":"e086208","DOI":"10.1136\/bmjopen-2024-086208","volume":"14","author":"RJ Hup","year":"2024","unstructured":"Hup RJ, Paauw ND, Lely AT, Depmann M. Oral antihypertensive agents and diuretics in the management of hypertension in postpartum women: a systematic review and meta-analysis. BMJ Open. 2024;14:e086208.","journal-title":"BMJ Open"},{"key":"1120_CR48","doi-asserted-by":"publisher","first-page":"S727","DOI":"10.1016\/j.ajog.2022.11.1215","volume":"228","author":"RR Rimsza","year":"2023","unstructured":"Rimsza RR, Goyal S, Barry VG, Raghuraman N, Carter EB, Rampersad RM, et al. Prediction of patients at highest risk for anti-hypertensive up titration in the postpartum period. Am J Obstet Gynecol. 2023;228:S727\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1120_CR49","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.3390\/jcm14113722","volume":"14","author":"E Piotrkowicz","year":"2025","unstructured":"Piotrkowicz E, Skrzypczyk P, Prejbisz A, Dobrowolski P, Gawlak M, Kosi\u0144ski P. Safety and risks of antihypertensive medications during breastfeeding: A review of current guidelines. J Clin Med. 2025;14:3722.","journal-title":"J Clin Med"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01120-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:03:50Z","timestamp":1773911030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01120-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1120"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01120-1","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}